Literature DB >> 18005242

Analysis of detergent-resistant membranes of Helicobacter pylori infected gastric adenocarcinoma cells reveals a role for MARK2/Par1b in CagA-mediated disruption of cellular polarity.

Zaher Zeaiter1, David Cohen, Anne Müsch, Fabio Bagnoli, Antonello Covacci, Markus Stein.   

Abstract

Detergent-resistant membranes of eukaryotic cells are enriched in many important cellular signalling molecules and frequently targeted by bacterial pathogens. To learn more about pathogenic mechanisms of Helicobacter pylori and to elucidate novel effects on host epithelial cells, we investigated how bacterial co-cultivation changes the protein composition of detergent-resistant membranes of gastric adenocarcinoma (AGS) tissue culture cells. Using iTRAQ (isobaric tags for relative and absolute quantification) analysis we identified several cellular proteins, which are potentially related to H. pylori virulence. One of the proteins, which showed a significant infection-dependent increase in detergent resistance, was the polarity-associated serine/threonine kinase MARK2 (EMK1/Par-1b). We demonstrate that H. pylori causes the recruitment of MARK2 from the cytosol to the plasma membrane, where it colocalizes with the bacteria and interacts with CagA. Using Mardin Darby Canine Kidney (MDCK) monolayers and a three-dimensional MDCK tissue culture model we showed that association of CagA with MARK2 not only causes disruption of apical junctions, but also inhibition of tubulogenesis and cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005242     DOI: 10.1111/j.1462-5822.2007.01084.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  40 in total

1.  EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.

Authors:  Rocio Tapia; Sarah E Kralicek; Gail A Hecht
Journal:  Cell Microbiol       Date:  2017-07-27       Impact factor: 3.715

2.  Role of partitioning-defective 1/microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA.

Authors:  Huaisheng Lu; Naoko Murata-Kamiya; Yasuhiro Saito; Masanori Hatakeyama
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

3.  CagA of Helicobacter pylori interacts with and inhibits the serine-threonine kinase PRK2.

Authors:  Jyoti Prasad Mishra; David Cohen; Andrea Zamperone; Dragana Nesic; Anne Muesch; Markus Stein
Journal:  Cell Microbiol       Date:  2015-06-19       Impact factor: 3.715

Review 4.  Modulation of epithelial cell polarity by bacterial pathogens.

Authors:  Rocio Tapia; Sarah E Kralicek; Gail A Hecht
Journal:  Ann N Y Acad Sci       Date:  2017-06-19       Impact factor: 5.691

Review 5.  Pathobiology of Helicobacter pylori-Induced Gastric Cancer.

Authors:  Manuel Amieva; Richard M Peek
Journal:  Gastroenterology       Date:  2015-09-16       Impact factor: 22.682

Review 6.  Helicobacter pylori CagA: a critical destroyer of the gastric epithelial barrier.

Authors:  Jia Wu; Song Xu; Yongliang Zhu
Journal:  Dig Dis Sci       Date:  2013-02-20       Impact factor: 3.199

7.  Conversion of Helicobacter pylori CagA from senescence inducer to oncogenic driver through polarity-dependent regulation of p21.

Authors:  Yasuhiro Saito; Naoko Murata-Kamiya; Toshiya Hirayama; Yusuke Ohba; Masanori Hatakeyama
Journal:  J Exp Med       Date:  2010-09-20       Impact factor: 14.307

Review 8.  Helicobacter pylori and gastric carcinogenesis.

Authors:  Masanori Hatakeyama
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

Review 9.  Type IV secretion systems: tools of bacterial horizontal gene transfer and virulence.

Authors:  Mario Juhas; Derrick W Crook; Derek W Hood
Journal:  Cell Microbiol       Date:  2008-06-10       Impact factor: 3.715

10.  Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche.

Authors:  Shumin Tan; Lucy S Tompkins; Manuel R Amieva
Journal:  PLoS Pathog       Date:  2009-05-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.